• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现(S)-6-甲氧基色满-3-羧酸(4-吡啶-4-基-苯基)-酰胺作为有效的和同工型选择性 ROCK2 抑制剂。

Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors.

机构信息

School of Chemical and Environment Engineering, Shanghai Institute of Technology, 100 Hai Quan Rd., Shanghai 201418, PR China.

School of Chemical and Environment Engineering, Shanghai Institute of Technology, 100 Hai Quan Rd., Shanghai 201418, PR China.

出版信息

Bioorg Med Chem. 2019 Apr 1;27(7):1382-1390. doi: 10.1016/j.bmc.2019.02.047. Epub 2019 Feb 22.

DOI:10.1016/j.bmc.2019.02.047
PMID:30819619
Abstract

ROCK1 and ROCK2 are highly homologous isoforms. Accumulated studies indicate that they have distinct different functions, and the development of isoform selective ROCK inhibitors will pave new roads for the treatment of various diseases. In this work, a series of amide-chroman derivatives were synthesized and biologically evaluated in order to develop potent and isoform selective ROCK2 inhibitors. Remarkably, (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide ((S)-7c) possessed ROCK2 inhibitory activity with an IC value of 3 nM and 22.7-fold isoform selectivity (vs. ROCK1). Molecular docking indicated that hydrophobic interactions were the key element for the high potency and isoform selectivity of (S)-7c. The binding free energies predicted by MM/GBSA were in good agreement with the experimental bioactivities, and the analysis of individual energy terms suggested that residue Lys105 in ROCK1 or Lys121 in ROCK2 was the key residue for the isoform selectivity of (S)-7c.

摘要

ROCK1 和 ROCK2 是高度同源的同工型。积累的研究表明,它们具有明显不同的功能,开发同工型选择性 ROCK 抑制剂将为治疗各种疾病开辟新的道路。在这项工作中,我们合成了一系列酰胺色满衍生物,并对其进行了生物评价,以期开发出强效且同工型选择性的 ROCK2 抑制剂。值得注意的是,(S)-6-甲氧基色满-3-羧酸(4-吡啶-4-基-苯基)-酰胺((S)-7c)对 ROCK2 具有抑制活性,IC 值为 3nM,对 ROCK1 的同工型选择性为 22.7 倍。分子对接表明,疏水相互作用是 (S)-7c 高活性和同工型选择性的关键因素。通过 MM/GBSA 预测的结合自由能与实验生物活性吻合较好,对单个能量项的分析表明,ROCK1 中的残基 Lys105 或 ROCK2 中的残基 Lys121 是 (S)-7c 同工型选择性的关键残基。

相似文献

1
Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors.发现(S)-6-甲氧基色满-3-羧酸(4-吡啶-4-基-苯基)-酰胺作为有效的和同工型选择性 ROCK2 抑制剂。
Bioorg Med Chem. 2019 Apr 1;27(7):1382-1390. doi: 10.1016/j.bmc.2019.02.047. Epub 2019 Feb 22.
2
Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.三嗪衍生物作为ROCK1抑制剂的发现与优化:分子对接、分子动力学模拟及自由能计算
Mol Biosyst. 2013 Mar;9(3):361-74. doi: 10.1039/c2mb25408e. Epub 2013 Jan 23.
3
Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as selective ROCK2 inhibitors with anti-breast cancer migration and invasion activities.发现新型吡唑并[1,5-a]嘧啶衍生物作为选择性 ROCK2 抑制剂,具有抗乳腺癌迁移和侵袭活性。
Bioorg Chem. 2024 Oct;151:107675. doi: 10.1016/j.bioorg.2024.107675. Epub 2024 Aug 2.
4
Discovery of a phenylpyrazole amide ROCK inhibitor as a tool molecule for in vivo studies.发现一种苯并吡唑酰胺 ROCK 抑制剂作为体内研究的工具分子。
Bioorg Med Chem Lett. 2020 Nov 1;30(21):127495. doi: 10.1016/j.bmcl.2020.127495. Epub 2020 Aug 13.
5
Chroman-3-amides as potent Rho kinase inhibitors.色满-3-酰胺类作为有效的Rho激酶抑制剂。
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6406-9. doi: 10.1016/j.bmcl.2008.10.080. Epub 2008 Oct 22.
6
Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitors.鉴定 5H-色烯并[3,4-c]吡啶和 6H-异色烯并[3,4-c]吡啶衍生物为强效和选择性双重 ROCK 抑制剂。
Bioorg Med Chem Lett. 2020 Nov 1;30(21):127474. doi: 10.1016/j.bmcl.2020.127474. Epub 2020 Aug 15.
7
Design, synthesis, and biological evaluation of urea-based ROCK2 inhibitors.基于脲的 ROCK2 抑制剂的设计、合成与生物评价。
Chem Biol Drug Des. 2021 Dec;98(6):969-978. doi: 10.1111/cbdd.13961. Epub 2021 Oct 5.
8
Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors.基于吡啶的Rho激酶(ROCK)抑制剂的设计、合成及构效关系
J Med Chem. 2015 Jun 25;58(12):5028-37. doi: 10.1021/acs.jmedchem.5b00424. Epub 2015 Jun 12.
9
Discovery of potent and selective urea-based ROCK inhibitors: Exploring the inhibitor's potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations.强效且选择性的基于尿素的ROCK抑制剂的发现:通过三维定量构效关系、分子对接和分子动力学模拟探索抑制剂的效力及ROCK2/PKA选择性
Bioorg Med Chem. 2015 May 15;23(10):2505-17. doi: 10.1016/j.bmc.2015.03.047. Epub 2015 Mar 25.
10
The selectivity and promiscuity of brain-neuroregenerative inhibitors between ROCK1 and ROCK2 isoforms: An integration of SB-QSSR modelling, QM/MM analysis and in vitro kinase assay.脑神经营养再生抑制剂在ROCK1和ROCK2亚型之间的选择性与混杂性:SB-QSSR建模、QM/MM分析及体外激酶测定的整合
SAR QSAR Environ Res. 2016;27(1):47-65. doi: 10.1080/1062936X.2015.1132765.

引用本文的文献

1
Therapeutic Efficacy of Small Extracellular Vesicles Loaded with ROCK Inhibitor in Parkinson's Disease.载有ROCK抑制剂的小细胞外囊泡在帕金森病中的治疗效果
Pharmaceutics. 2025 Mar 13;17(3):365. doi: 10.3390/pharmaceutics17030365.
2
Multitargeting the Action of 5-HT Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View?通过对激酶的额外调节来靶向 5-HT 血清素受体配体的作用,以寻找阿尔茨海默病的新疗法:从分子角度看,它能行吗?
Int J Mol Sci. 2022 Aug 7;23(15):8768. doi: 10.3390/ijms23158768.
3
Computer-aided discovery of phenylpyrazole based amides as potent S6K1 inhibitors.
基于苯并吡唑的酰胺类化合物作为强效S6K1抑制剂的计算机辅助发现
RSC Med Chem. 2020 Apr 30;11(5):583-590. doi: 10.1039/c9md00537d. eCollection 2020 May 1.
4
Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer.开发 2-(4-吡啶基)苯并咪唑作为 PKN2 的化学工具来探索癌症。
Bioorg Med Chem Lett. 2020 Apr 15;30(8):127040. doi: 10.1016/j.bmcl.2020.127040. Epub 2020 Feb 17.